These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6861770)

  • 1. Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication.
    Bogaert MG; Clement DL
    Eur Heart J; 1983 Mar; 4(3):203-4. PubMed ID: 6861770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of muliple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease.
    Tivenius L
    Scand J Respir Dis; 1976; 57(4):190-6. PubMed ID: 790561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ; Lindner PC
    Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise metabolism during 1 hour of treadmill walking while taking high and low doses of propranolol, metoprolol, or placebo.
    Head A; Kendall MJ; Maxwell S
    Clin Cardiol; 1995 Jun; 18(6):335-40. PubMed ID: 7664508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of propranolol and metoprolol on peripheral circulation in intermittent claudication].
    Diehm C; Mörl H; Schettler G
    Vasa; 1983; 12(1):59-63. PubMed ID: 6837129
    [No Abstract]   [Full Text] [Related]  

  • 7. Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa.
    Lepäntalo M; von Knorring J
    Clin Physiol; 1984 Aug; 4(4):275-82. PubMed ID: 6380905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of intermittent claudication: a comparative double-blind study of suloctidil, dihydroergotoxine and placebo.
    Adriaensen H
    Curr Med Res Opin; 1976; 4(6):395-401. PubMed ID: 793778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Herbert M; Skene AM
    Br J Clin Pharmacol; 1984 Mar; 17(3):273-81. PubMed ID: 6712861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal shockwave therapy for intermittent claudication: Medium-term outcomes from a double-blind randomised placebo-controlled pilot trial.
    Green JL; Harwood AE; Smith GE; Das T; Raza A; Cayton T; Wallace T; Carradice D; Chetter IC
    Vascular; 2018 Oct; 26(5):531-539. PubMed ID: 29722640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of oral metoprolol and propranolol in patients with chronic bronchitis.
    Anderson G; Jariwalla AG; Al-Zaibak M
    J Int Med Res; 1980; 8(2):136-8. PubMed ID: 6989683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction.
    McGavin CR; Williams IP
    Br J Dis Chest; 1978 Oct; 72(4):327-32. PubMed ID: 365214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of supervised exercise therapy for intermittent claudication on lower limb lean mass.
    Vun SV; Miller MD; Delaney CL; Allan RB; Spark JI
    J Vasc Surg; 2016 Dec; 64(6):1763-1769. PubMed ID: 27633168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P; Migliacci R; Di Sante G; Nenci GG;
    Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoprolol in essential tremor.
    Ljung O
    Lancet; 1980 May; 1(8176):1032. PubMed ID: 6103362
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.
    Lager I; Blohmé G; Smith U
    Lancet; 1979 Mar; 1(8114):458-62. PubMed ID: 85053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.